← Leaderboards
Sonia Sharma
La Jolla Institute For Immunology
$3,824,546
Attributed
$5,599,051
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $783.4K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,599,051 · 3
By mechanism
R01$5,561,302 · 2
U19$37,749 · 1
Top collaborators
- Edward A Dennis3 shared
- Mohit Jain2 shared
Most similar at La Jolla Institute For Immunology
Same institution · by research overlap
- Pandurangan Vijayanand$21,136,772
- Ferhat Ay$7,327,013
- Christian Hermann Heinrich Ottensmeier$1,200,707
- Benjamin Joachim Schmiedel$1,980,136
Others in their field
Top investigators on “Immunity”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmunityCancer PatientImmuneMalignant Neoplasm Of LungSignal TransductionCancer TherapyImmunologistInflammatoryIn VivoCellsPlaySamplingTumorBone MarrowMalignant NeoplasmsInnovationImmunotherapeutic AgentImmunotherapyCancer ImmunotherapyBaseAutoimmuneApplications GrantsAnti-Ctla4Colitis
Grant awards (11)
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy$693,716
R01 · FY2025 · CA · contact PI
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy$659,355
R01 · FY2024 · CA · contact PI
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy$706,097
R01 · FY2023 · CA · contact PI
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy$706,425
R01 · FY2022 · CA · contact PI
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy$783,417
R01 · FY2021 · CA · contact PI
Targeting tumor endothelium for cancer surveillance and immunotherapy$392,740
R01 · FY2019 · CA · contact PI
Targeting tumor endothelium for cancer surveillance and immunotherapy$404,888
R01 · FY2018 · CA · contact PI
Targeting tumor endothelium for cancer surveillance and immunotherapy$404,888
R01 · FY2017 · CA · contact PI
Targeting tumor endothelium for cancer surveillance and immunotherapy$404,888
R01 · FY2016 · CA · contact PI
Targeting tumor endothelium for cancer surveillance and immunotherapy$404,888
R01 · FY2015 · CA · contact PI
ShRNAmir-RV Library Storage and Dissemination$37,749
U19 · FY2014 · AI · contact PI